Follow the Turnstone Biologics Corp. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €4.1m. The latest transaction was filed on 12 August 2025 (U). Among the most active insiders: ORBIMED ADVISORS LLC. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Turnstone Biologics Corp. es una empresa biofarmacéutica centrada en el desarrollo de inmunoterapias para el tratamiento del cáncer. Cotiza en NASDAQ bajo el ticker XNAS.